Mutations Identified in a Cohort of Mexican Patients with Lysosomal Acid Lipase Deficiency

2018 ◽  
Vol 17 (5) ◽  
pp. 0-10
Author(s):  
Alejandra Consuelo-Sánchez ◽  
Rodrigo Vázquez-Frías ◽  
Alejandra Reyes-De la Rosa ◽  
Carlos P. Acosta-Rodríguez-Bueno ◽  
María P. Ortal-Vite ◽  
...  

Introduction and aim. Lysosomal acid lipase deficiency (LAL-D) is an autosomal recessive disease caused by mutations in the LIPA gene, located on the long arm of chromosome 10 (10q23.31). Up until now, more than 59 mutations have been described and which are the cause of a very wide clinical spectrum. The goal of this study was to identify the mutations present in Mexican pediatric patients with a diagnosis of LAL-D. Material and methods. A cross-sectional study was carried out which included all the pediatric patients with LAL-D treated in a tertiary hospital in Mexico from January 2000 to June 2017. Results. Sixteen patients with LAL-D were identified with a disease phenotype marked by the accumulation of cholesteryl esters. Eight distinct variants in the LIPA gene sequence were found, four pathogenic variants and four probably pathogenic. In six individuals, the variants were found in the homozygous state and ten were compound heterozygous. The eight variants were inverted, with five found on exon 4 and the others on exons 2, 8 and 10. The variant c.386A>G;p.His129Arg was the most common, being found in six of the 16 individuals (37.5%), making it much more frequent than what had previously been reported in the literature in proportion to the rest of the variants. The mutation known as E8SJM, which has been the mostly frequently found at the international level, was not the most common among this group of Mexican patients. Conclusion. Mexican patients present a different frequency of mutations associated with LAL-D in comparison to European populations.

Author(s):  
David A. Suarez-Zamora ◽  
Maria M. Rojas-Rojas ◽  
Felipe Ordoñez-Guerrero ◽  
Jacqueline Mugnier-Quijano ◽  
Rocio Lopez-Panqueva

2021 ◽  
Vol 4 (Supplement_1) ◽  
pp. 248-249
Author(s):  
M Francis ◽  
M Balwani ◽  
W Balistreri ◽  
L D’Antiga ◽  
S Fang ◽  
...  

Abstract Background Lysosomal acid lipase deficiency (LAL-D) is a rare, autosomal recessive disease caused by pathogenic variants in the LIPA gene. Lysosomal accumulation of cholesteryl esters and triglycerides leads to cirrhosis and dyslipidemia across a clinical spectrum, and affect both infants and children/adults. Aims An international registry (NCT01633489; Alexion Pharmaceuticals, Inc.; 2013–ongoing) was established to better understand the natural history of lysosomal acid lipase deficiency (LAL-D) and to evaluate long-term treatment outcomes. Methods Baseline findings for patients enrolled through July 1, 2019 are presented. Of 190 patients enrolled, 35 were excluded from this analysis (LIPA carrier, deceased at enrollment, unconfirmed LAL-D diagnosis); 155 patients with confirmed LAL-D diagnosis were included (12 infants, 143 children/adults). LAL enzyme activity analysis was performed for 145/154 patients (94%) and genetic testing for 128/154 patients (83%). Results Of 105 children/adults with reported LIPA mutations, 39 were homozygous and 34 were compound heterozygous for the common LIPA mutation E8SJM (c.894G>A); 6 infants with reported LIPA mutations were homozygotes and 2 were compound heterozygotes. Of the 155 patients, 62% were <18 years, 52% were male, and 85% were white. Median (range) age at clinical onset was 0.2 years (0.0–0.7) among infants and 6.0 years (0.0–41.3) among 133 children/adults with data; median (range) age at diagnosis was 0.2 years (−0.1 to 1.2) among infants and 10.8 years (0.2–53.6) among 135 children/adults with data. Manifestations that raised suspicion of LAL-D were reported in 149/155 patients. Infants (12 with data) presented predominantly with hepatomegaly (75%), splenomegaly (58%), nausea/vomiting (58%), and diarrhea (50%), and 50% had a known family history of LAL-D. Children/adults (n=143) presented predominantly with elevated alanine aminotransferase levels (67%), hepatomegaly (66%), and elevated aspartate aminotransferase levels (65%). Of 74 children/adults with baseline liver biopsy, 58% had microvesicular steatosis, 16% had micro- and macrovesicular steatosis, and 32% had lobular inflammation. Of the 155 patients, 6% had a medical history of cirrhosis. Analyses exploring the genotype-phenotype relationship will be presented. Conclusions Registry data of >150 LAL-D patients demonstrate early symptom onset, variable clinical manifestations, and a significant diagnostic delay in children/adults. Funding Agencies Alexion Pharmaceuticals, Inc.


2019 ◽  
Vol 13 (3) ◽  
pp. 498-507
Author(s):  
Maria Zharkova ◽  
Tatiana  Nekrasova ◽  
Vladimir  Ivashkin ◽  
Marina  Maevskaya ◽  
Tatyana Strokova

Lysosomal acid lipase deficiency (LALD) is a rare genetic disease characterized by the accumulation of cholesteryl esters and triglycerides in many organs, including the liver, spleen, lymph nodes, bone marrow, and vascular endothelium. Patients with LALD can appear asymptomatic until liver failure or premature sudden death from coronary artery disease, stroke, and aneurysm, which lead to the diagnosis. Herein, we present a diagnostic workup in a young 17-year-old female patient who manifested hepatosplenomegaly, elevated liver enzymes, severe dyslipidemia, and systemic atherosclerosis. Liver biopsy demonstrated over 90% diffuse microvesicular steatosis, lipid accumulation in Kupffer cells, and birefringent cholesteryl ester crystals. The diagnosis of LALD was proven by the decrease of lysosomal acid lipase activity in dried blood spots and by the detection of two compound heterozygous mutations in the LIPA gene: nonsense mutation G796T (Gly266Term) and splicing site mutation G894A (E8SJM). The patient started enzyme replacement therapy with sebelipase alfa. Following the 1-year treatment, the patient remained asymptomatic, her serum aminotransferase levels were normal, liver density increased due to lipid resorption, and plaque-associated stenosis of carotid artery regressed. Moreover, liver biopsy showed a decrease of cholesteryl ester crystals in Kupffer cells.


2019 ◽  
Vol 18 (4) ◽  
pp. 646-650 ◽  
Author(s):  
Alejandra Consuelo-Sánchez ◽  
Rodrigo Vázquez-Frias ◽  
Alejandra Reyes-De La Rosa ◽  
Carlos P. Acosta-Rodríguez-Bueno ◽  
María P. Ortal-Vite ◽  
...  

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Suresh Vijay ◽  
Anais Brassier ◽  
Arunabha Ghosh ◽  
Simona Fecarotta ◽  
Florian Abel ◽  
...  

An amendment to this paper has been published and can be accessed via the original article.


2019 ◽  
Vol 68 (3) ◽  
pp. 371-376
Author(s):  
Zarife Kuloglu ◽  
Aydan Kansu ◽  
Suna Selbuz ◽  
Ayhan G. Kalaycı ◽  
Gülseren Şahin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document